Evidence map›Paper›PMID 26464851›Full record

ArticleInternational journal of chronic diseases2014

Activation of Natural Killer Cells in Patients with Chronic Bone and Joint Infection due to Staphylococci Expressing or Not the Small Colony Variant Phenotype.

Sébastien Viel, Paul Rouzaire, Frédéric Laurent, Thierry Walzer, Jacques Bienvenu, Florent Valour, Christian Chidiac, Tristan Ferry, The Lyon Bji Study Group

Open access · hybridAbstract read
In one paragraph

Article in International journal of chronic diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Sébastien VielLaboratoire d'Immunologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France ; Université Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France.
Paul RouzaireLaboratoire d'Immunologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France ; Université Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France.
Frédéric LaurentUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France ; Laboratoire de Bactériologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France ; Centre National de Référence des Staphylocoques, 69008 Lyon, France.
Thierry WalzerUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France.
Jacques BienvenuLaboratoire d'Immunologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France ; Université Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France.
Florent ValourUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France ; Centre National de Référence des Staphylocoques, 69008 Lyon, France ; Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 93 Grande rue de la Croix-Rousse, 69004 Lyon, France ; Centre Interrégional Rhône-Alpes Auvergne de Référence des IOA Complexes, 69004 Lyon, France.
Christian ChidiacUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France ; Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 93 Grande rue de la Croix-Rousse, 69004 Lyon, France ; Centre Interrégional Rhône-Alpes Auvergne de Référence des IOA Complexes, 69004 Lyon, France.
Tristan FerryUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France ; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, 69007 Lyon, France ; Centre National de Référence des Staphylocoques, 69008 Lyon, France ; Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 93 Grande rue de la Croix-Rousse, 69004 Lyon, France ; Centre Interrégional Rhône-Alpes Auvergne de Référence des IOA Complexes, 69004 Lyon, France.
The Lyon Bji Study GroupUniversité Claude Bernard Lyon 1, 69100 Villeurbanne, France.
Centre International de Recherche en Infectiologie · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRÉcole Normale Supérieure de Lyon · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic bone and joint infections (BJI) are devastating diseases. Relapses are frequently observed, as some pathogens, especially staphylococci, can persist intracellularly by expressing a particular phenotype called small colony variant (SCV). As natural killer (NK) cells are lymphocytes specialized in the killing of host cells infected by intracellular pathogens, we studied NK cells of patients with chronic BJI due to staphylococci expressing or not SCVs (10 patients in both groups). Controls were patients infected with other bacteria without detectable expression of SCVs, and healthy volunteers. NK cell phenotype was evaluated from PBMCs by flow cytometry. Degranulation capacity was evaluated after stimulation with K562 cells in vitro. We found that NK cells were activated in terms of CD69 expression, loss of CD16 and perforin, in all infected patients in comparison with healthy volunteers, independently of the SCV phenotype. Peripheral NK cells in patients with chronic BJI display signs of recent activation and degranulation in vivo in response to CD16-mediated signals, regardless of the type of bacteria involved. This could involve a universal capacity of isolates responsible for chronic BJI to produce undetectable SCVs in vivo, which might be a target of future intervention.

Identifiers

PMID26464851
PMCPMC4590914
OpenAlexW2080150147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.